| Vincent B. Ciofalo,
Ph.D. |
|
|
| |
|
|
|
Expert Toxicology Consultant /
Toxicologist |
| |
- Preclinical Development Program Design
& Monitoring
|
|
Areas of Toxicology Expertise:
|
| |
- New Drug Research & Development
Design & Management
- Drug Metabolism
- Pharmacokinetics
- Toxicology & Clinical Study
Design
- Monitoring & Evaluation;
- Regulatory Affairs (GLP, GCP, cGMP, IND,
NDA)
- Assist Pharmaceutical Business &
Trade in China
|
|
Description: |
| |
7 years Quality Control
Management; Over 15 years in directing New Drug Research &
Development; Over 10 years as part-time Consultant; 10 years as
Adjunct Professor of Pharmacology & Toxicology. Diplomate,
American Board of Forensic Examiners & American Board of Forensic
Medicine |
|
Contact information: |
| |
Vincent B. Ciofalo
The Summit Group
P.O. Box 756
Waverly, Pennsylvania 18471
Phone: (570) 586-4193
Fax: (570) 585-8990
e-mail:
vbc (at) epix.net
Website:http://rtctox.com/ciofalo.htm
|
|
|
Forensic Expert Witness: |
| |
Willing to
serve as Expert
Witness |
|
| |
Experience
as Expert Witness |
|
|
|
|
|
Dictionary of
Abbreviations and Acronyms used: |
| Glp |
Good Laboratory Practice |
|
| Gcp |
Good Clinical Practice |
| cGMP |
Current Good Manufacturing Practice |
|
| Ind |
Investigational New Drug (Exemption) |
|
| Nda |
New Drug Application |
|